Section Arrow
LENZ.NASDAQ
- LENZ Therapeutics
Quotes are at least 15-min delayed:2024/05/12 20:55 EDT
Last
 15.73
+0.33 (+2.14%)
Day High 
16.015 
Prev. Close
15.4 
1-M High
22.07 
Volume 
160.99K 
Bid
15.64
Ask
18.12
Day Low
15.18 
Open
15.37 
1-M Low
15 
Market Cap 
393.22M 
Currency USD 
P/E -- 
%Yield 32.39 
10-SMA 16.1 
20-SMA 16.88 
50-SMA 19.79 
52-W High 29.82 
52-W Low 14.0707 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.18/-0.89
Enterprise Value
393.36M
Balance Sheet
Book Value Per Share
-3.63
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NVAXNovavax8.88+4.41+98.66%-- 
DNAGinkgo Bioworks Holdings0.7609-0.1591-17.29%-- 
MGNXMacroGenics3.31-11.36-77.44%-- 
JAGXJaguar Health0.2921-0.0174-5.62%-- 
IOVAIovance Biotherapeutics10.965-2.485-18.48%-- 
Quotes are at least 15-min delayed:2024/05/12 20:55 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.